Thiago M Cunha Selected Research

budlein A

1/2018	Budlein A, a Sesquiterpene Lactone From Viguiera robusta, Alleviates Pain and Inflammation in a Model of Acute Gout Arthritis in Mice.
12/2017	Erratum to: The Sesquiterpene Lactone, Budlein A, Inhibits Antigen-Induced Arthritis in Mice: Role of NF-κB and Cytokines.
12/2017	The Sesquiterpene Lactone, Budlein A, Inhibits Antigen-Induced Arthritis in Mice: Role of NF-κB and Cytokines.
5/2007	Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thiago M Cunha Research Topics

Disease

52	Pain (Aches) 01/2022 - 11/2005
47	Hyperalgesia 05/2022 - 11/2005
42	Inflammation (Inflammations) 08/2022 - 06/2006
30	Arthritis (Polyarthritis) 01/2022 - 08/2004
12	Edema (Dropsy) 01/2022 - 09/2014
12	Experimental Arthritis 01/2018 - 05/2011
11	Infections 01/2021 - 05/2012
11	Rheumatoid Arthritis 01/2018 - 06/2006
10	Neuralgia (Stump Neuralgia) 01/2020 - 11/2014
8	Hypersensitivity (Allergy) 05/2022 - 11/2008
7	Chronic Pain 05/2019 - 03/2010
6	COVID-19 10/2022 - 01/2021
6	Neoplasms (Cancer) 11/2021 - 04/2011
6	Gout 12/2020 - 02/2012
6	Necrosis 04/2015 - 05/2007
4	Sepsis (Septicemia) 01/2022 - 09/2012
4	Melanoma (Melanoma, Malignant) 11/2021 - 01/2012
3	Autoimmune Diseases (Autoimmune Disease) 08/2022 - 09/2015
3	Synovitis 03/2020 - 09/2015
3	Hypertension (High Blood Pressure) 10/2017 - 12/2011
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2016
2	Osteoarthritis 12/2020 - 01/2018
2	Gouty Arthritis 12/2020 - 01/2018
2	Colitis 01/2020 - 01/2015
2	Peripheral Nerve Injuries 01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

48	CytokinesIBA 08/2022 - 11/2005
20	AntigensIBA 01/2022 - 07/2007
15	Analgesics (Analgesic Drugs)IBA 01/2019 - 08/2007
13	CarrageenanIBA 01/2022 - 10/2010
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2005
11	Peroxidase (Myeloperoxidase)IBA 01/2017 - 03/2009
10	ChemokinesIBA 01/2020 - 10/2006
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2021 - 08/2013
8	Superoxides (Superoxide)IBA 12/2020 - 07/2015
8	ProstaglandinsIBA 01/2020 - 05/2007
8	LipopolysaccharidesIBA 08/2017 - 08/2013
7	Interleukin-17 (Interleukin 17)IBA 08/2022 - 04/2009
7	Interleukin-33IBA 01/2022 - 09/2010
7	InflammasomesIBA 01/2021 - 02/2012
7	Interleukin-18 (Interleukin 18)IBA 01/2021 - 07/2007
7	Endothelins (Endothelin)IBA 01/2017 - 11/2005
6	Interleukin-6 (Interleukin 6)IBA 12/2021 - 10/2015
6	Interleukin-10 (Interleukin 10)IBA 12/2021 - 02/2015
6	Dinoprostone (PGE2)FDA Link 04/2021 - 07/2008
6	Type I Tumor Necrosis Factor ReceptorsIBA 10/2017 - 04/2014
5	Messenger RNA (mRNA)IBA 01/2022 - 04/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
5	Etanercept (Enbrel)FDA Link 05/2021 - 04/2014
5	ZymosanIBA 08/2016 - 06/2006
4	methylated bovine serum albumin (MBSA)IBA 01/2022 - 02/2010
4	Uric Acid (Urate)IBA 12/2020 - 01/2018
4	LigandsIBA 01/2019 - 02/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2009
4	budlein AIBA 01/2018 - 05/2007
4	Acetic Acid (Vinegar)FDA LinkGeneric 10/2017 - 05/2012
4	Leukotriene B4IBA 08/2017 - 12/2007
4	KATP ChannelsIBA 08/2017 - 05/2012
4	AntioxidantsIBA 07/2017 - 09/2014
4	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2016 - 01/2012
4	InterleukinsIBA 03/2015 - 08/2004
4	Morphine (MS Contin)FDA LinkGeneric 02/2015 - 11/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 10/2018
3	Therapeutic UsesIBA 12/2021 - 01/2015
3	Phosphotransferases (Kinase)IBA 12/2021 - 04/2011
3	prolinedithiocarbamate (PDTC)IBA 05/2021 - 09/2014
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 02/2015
3	Opioid Analgesics (Opioids)IBA 01/2020 - 04/2011
3	potassium superoxideIBA 01/2019 - 09/2015
3	FlavonoidsIBA 06/2018 - 08/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 09/2010
3	SesquiterpenesIBA 01/2018 - 12/2017
3	LactonesIBA 01/2018 - 12/2017
3	Ethanol (Ethyl Alcohol)IBA 10/2017 - 12/2011
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 08/2017 - 02/2012
3	nitroxylIBA 08/2016 - 08/2013
3	oxyhyponitriteIBA 08/2016 - 08/2013
3	Endothelin Receptor AntagonistsIBA 11/2015 - 03/2009
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2015 - 04/2014
3	Indomethacin (Indometacin)FDA LinkGeneric 02/2015 - 11/2005
2	Propolis (Bee Bread)IBA 08/2022 - 11/2016
2	Antineoplastic Agents (Antineoplastics)IBA 05/2022 - 10/2018
2	Formaldehyde (Formol)FDA Link 01/2022 - 09/2014
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022 - 08/2020
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2021 - 07/2014
2	KininsIBA 01/2021 - 11/2007
2	SmokeIBA 01/2021 - 01/2018
2	Toll-Like Receptor 4IBA 01/2020 - 01/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 01/2015
2	Epinephrine (Adrenaline)FDA LinkGeneric 08/2019 - 08/2018
2	Type II Tumor Necrosis Factor ReceptorsIBA 05/2019 - 09/2015
2	vinpocetineIBA 01/2019 - 07/2015
2	Proteoglycans (Proteoglycan)IBA 12/2018 - 12/2017
2	naringeninIBA 12/2018 - 01/2016

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2005
4	Ligation 01/2022 - 09/2012
3	Analgesia 01/2022 - 08/2014
2	Punctures 01/2022 - 09/2012
2	Cryotherapy (Therapy, Cold) 01/2022 - 01/2022
2	Intra-Articular Injections 01/2020 - 06/2018
2	Aftercare (After-Treatment) 10/2018 - 08/2017